1. The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies
- Author
-
Wang F, Zhao Q, He HR, Zhai YJ, Lu J, Hu HB, Zhou JS, Yang YH, and Li YJ
- Subjects
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 - Abstract
Fang Wang,1,2,* Qian Zhao,1,2,* Hai-rong He,3 Ya-jing Zhai,4 Jun Lu,3 Hai-bo Hu,1 Jin-song Zhou,1 Yong-hua Yang,5 Yuan-jie Li1 1Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Centre, 2College of Pharmacy, Xi’an Medical University, 3Clinical Research Center, 4Department of Pharmacy, 5Department of Pediatrics, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, People’s Republic ofChina *These authors contributed equally to this work Background: Associations between Arg399Gln single-nucleotide polymorphism (SNP) in the XRCC1 gene and leukemia susceptibility have been studied extensively, however, the results are inconsistent. The aim of this study was to determine these associations using meta-analytical methods.Methods: A meta-analysis was performed to examine the associations between XRCC1 Arg399Gln SNP and leukemia risk. A literature search of PubMed and Web of Science databases was conducted to identify relevant studies published up to March 10, 2015. The references of the retrieved articles were also screened. All the statistical analyses were conducted using Review Manager software.Results: The XRCC1 Arg399Gln SNP was found to be associated with increased childhood risk of acute lymphoblastic leukemia among Asians under the dominant (odds ratio [OR] 2.11, 95% confidence interval [CI] 1.50–2.97, P
- Published
- 2015